Repligen Corp
RGEN: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|L# | LOCK|<b<<! | LOCK|W<>^#zK |
Repligen Earnings: Double-Digit Top-Line Growth Supports Recovery
Repligen reported year-on-year revenue growth of 10% and an adjusted operating margin of 13.8%, which is 4.9 percentage points better than the same period last year. The company refreshed its full-year guidance ranges, with slightly better revenue offset by slightly worse margins.
